The experiments performed in this study comply with the current national laws in the country in which they were performed. The authors declare no conflict of interest.
Characterization of NF1 allele containing two nonsense mutations in exon 37 that segregates with neurofibromatosis type 1
Article first published online: 10 SEP 2012
© 2012 John Wiley & Sons A/S
Volume 83, Issue 5, pages 462–466, May 2013
How to Cite
Characterization of NF1 allele containing two nonsense mutations in exon 37 that segregates with neurofibromatosis type 1., , , , , , , .
- Issue published online: 5 APR 2013
- Article first published online: 10 SEP 2012
- Accepted manuscript online: 24 AUG 2012 02:45AM EST
- Manuscript Accepted: 7 AUG 2012
- Manuscript Revised: 31 JUL 2012
- Manuscript Received: 31 MAY 2012
- Asociación de Afectados de Neurofibromatosis (AANF). Grant Number: FIS PI10/00563
- Departamento de Educación, Universidades e Investigación del Gobierno Vasco
- double mutation;
- exon skipping;
- exonic splicing enhancer;
- neurofibromatosis type 1;
- splicing mutations
Neurofibromatosis type 1 (NF1) is a common autosomal dominant disease caused by mutations in the NF1 gene. The mutation rate of NF1 is one of the highest known for human genes and the mutational analysis has revealed a wide variety of changes, a significant proportion of which affect normal pre-mRNA splicing. Here, we describe two truncating mutations in exon 37 of NF1, the recurrent c.6792C>A and the novel c.6799C>T change, that occur in cis and segregate with NF1 in a large family. The double mutation induces defective splicing of exon 37 and thus, we performed quantitative comparisons of transcripts harboring single (c.6792C>G or c.6792C>A) and double (c.6792C>A and c.6799C>T) mutations to assess their effects on exon 37 splicing. Skipping of exon 37 was greater and there were fewer mutant full-length transcripts in samples with the double mutation than in those carrying single mutations. Thus, the combination of the c.6792C>A and c.6799C>T mutations augmented exon 37 skipping. These findings suggest that, in addition to the previously described exonic splicing enhancer in the c.6791_6795 region, c.6799 lies within an additional regulatory element that influences the splicing of exon 37.